Roche buys Lonza’s Singapore unit
Swiss chemicals group Lonza said Monday it will sell a manufacturing facility in Singapore to Roche for USD 360 million.Zurich -- Swiss chemicals group Lonza said Monday it signed a deal to sell a manufacturing facility in Singapore to a Roche-owned subsidiary for up to USD 360 million (CHF 384 million, EUR 252 million).
The purchase price of the cell culture biologic manufacturing facility was USD 290 million while an additional USD 70 million would be paid up if certain milestones were met, Lonza said in a statement.
Swiss pharmaceutical giant Roche said the facility will be merged with an existing facility run by its subsidiary Genentech Singapore.
Some 230 Lonza employees at the site would also join Genentech Singapore.
AFP / Expatica